This study aimed to evaluate whether excessive body weight and the COVID-19 pandemic affect depression, and subsequently whether depression, excessive body weight, and the COVID-19 pandemic affect the course of pregnancy, as well as the well-being of a newborn. The research material included data retrieved from the medical records of 280 pregnant women who were provided with care by medical facilities in Lublin (100 women with normal weight, 100 overweight women, 50 with Class I and 30 with Class II obesity). They completed a Beck depression inventory (BDI) in pregnancy twice, in order to assess the risk of occurrence of postpartum depression. Pre-pregnancy BMI positively correlated with the severity of depression, both at 10–13 weeks of pregnancy (p < 0.001), and at 32 weeks of pregnancy (p < 0.001). The higher the pre-pregnancy BMI, on average the higher the severity of depression. The severity of depression was significantly higher during the pandemic than before it in women with normal body weight before pregnancy (p < 0.001), as well as in those overweight (p < 0.001) and with Class II obesity (p = 0.015). Excessive body weight before pregnancy leads to depressive disorders during pregnancy, increases the risk of preterm delivery, and exerts a negative effect on the state of a newborn. Depressive symptoms among pregnant, overweight and obese women intensified during the COVID-19 pandemic.

We report a case of monitoring the antibody response to the BioNTech–Pfizer vaccine of a 50-year-old female diagnosed with rheumatoid arthritis undergoing treatment with methotrexate (MTX). Antibody levels were measured 21 days after dose 1 (i.e., on the day of dose 2) and then 8, 14 and 30 days after dose 2 with Elecsys Anti-SARS-CoV-2 S assay (Roche Diagnostics). Patient showed a negative result after dose 1 and had the serum sample retested using a LIAISON® SARS-CoV-2 TrimericS IgG assay (DiaSorin), which showed a positive result. Subsequent samples were tested using both assays. Antibody levels kept increasing but at a much slower rate than in patients not receiving any immunomodulatory therapies. Other research indicates that among patients with autoimmune diseases, those receiving disease-modifying antirheumatic drugs (DMARDs) have higher COVID-19 mortality than those treated with tumor necrosis factor inhibitors (TNFis). These results indicate the need for people with autoimmune diseases to be carefully observed following vaccinations, including testing of antibody levels, and treated as potentially at risk until the effect of vaccination is confirmed. The different available vaccines should also be tested to verify their usefulness in the case of people with autoimmune diseases and those who take different immunomodulatory medications.

No abstract

Cel pracy. Celem pracy było zbadanie stanu wiedzy kobiet po porodzie na temat karmienia naturalnego. Materiał i metodyka. W badaniu wzięło udział 300 kobiet po porodzie w wieku od 18 do 41 lat. Narzędziem badawczym był autorski kwestionariusz ankiety. Uzyskane wyniki badań zostały poddane analizie statystycznej i opisowej z zastosowaniem oprogramowana STATISTICA 12.0 (StatSoft). Dla cech jakościowych do wykrycia istnienia zależności pomiędzy analizowanymi zmiennymi użyto testu Chi 2. Wyniki. Wśród ankietowanych 83,33% kobiet uważało, iż karmienie piersią należy rozpocząć w ciągu dwóch godzin po porodzie. Zauważono istotną statystycznie zależność pomiędzy wiedzą na ten temat a miejscem zamieszkania, statusem socjoekonomicznym oraz sposobem zakończenia ciąży. Wykazano także związek pomiędzy wiedzą na temat zaleceń WHO co do najkrótszego okresu wyłącznego karmienia piersią a wykształceniem oraz liczbą posiadanych dzieci. Najwięcej respondentek uznało Internet i telewizję jako kluczowe źródła, z których czerpią wiedzę na temat karmienia. Wnioski. Ankietowane biorące udział w badaniu prezentowały bardzo wysoki poziom wiedzy odnośnie do zaleceń związanych z karmieniem naturalnym.

Aesthetic gynecologic surgery is gaining popularity among women and physicians. Aesthetic genital surgery for women encompasses both minimally invasive and open surgical procedures. Cosmetic genital procedures for women described in this article include perineoplasty, vaginoplasty, vaginal rejuvenation, labiaplasty, G-spot enlargement, Bartholin gland surgery, clitoral hoodoplasty, clitroplasty, hymenoplasty, and mons pubis plastic surgery. Based on a review of the literature for each procedure, the article discusses procedural methods and techniques, indications for implementation, potential consequences and side effects of the procedure, nursing implications, patients' motives for undergoing the procedure, and positions of scientific institutions relative to the procedure.